REFERENCES
- Bunnag, D. & Harinasuta, T. (1987). The current status of drug resistance in malaria. International Journal for Parasitology, 17, 169–180.
- Bunnag, D., Viravan, C., Looareesuwan, S., Karbwang, J. & Harinasuta, T. (1991). Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand: a preliminary report. Southeast Asian Journal of Tropical Medicine and Public Health, 22, 380–385.
- Chongsuphajaisiddhi, T., Sabcharoen, A., Chanthavanich, P., Singhasivanon, V., Wernsdorfer, W. H. & Sheth, U. K. (1987). A phase III clinical trial of mefloquine in children with chloroquine-resistant falciparum malaria in Thailand. Bulletin of the World Health Organization, 65, 223–226.
- Harinasuta, T., Bunnag, D., Vanijanonta, S., Charoenlarp, P., Suntharasamai, P., Chittamas, S., Sheth, U. K. & Wernsdorfer, W. H. (1987). Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose. Bulletin of the World Health Organization, 63, 363–367.
- Klayman, D. L. (1985). Qjnghaosu (artemisinin): an antimalarial drug from China. Science, 228, 1049–1055.
- Looareesuwan, S., Harinasuta, T. & Chongsuphajaisiddhi, T. (1992a). Drug resistant malaria with special reference to Thailand. Southeast Asia Journal of Tropical Medicine and Public Health, 23, 621–634.
- Looareesuwan, S., Kyle, D. E., Viravan, C., Vanijanonta, S., Wilairatana, P., Charoenlarp, P., Canfield, C. J. & Webster, H. K. (1992b). Treatment of patients with recrudescent falciparum malaria with a sequential combination of artesunate and mefloquine. American Journal of Tropical Medicine and Hygiene, 47, 794–799.
- Looareesuwan, S., Viravan, C., Vanijanonta, S., Wilairatana, P., Charoenlarp, P., Canfield, C. & Kyle, D. E. (1993). Treatment of acute uncomplicated falciparum malaria with a short course of artesunate followed by mefloquine. Southeast Asian Journal of Tropical Medicine and Public Health, 24, 230–234.
- Looareesuwan, S., Viravan, S., Vanijanonta, S., Wijlairatana, P., Suntharasamai, P., Charoenlarp, P., Arnold, K., Kyle, D. E., Canfield, C. & Webster, K. (1992c). A randomised trial of mefloquine, artesunate and artesunate followed by mefloquine in acute uncomplicated falciparum malaria. Lancet, i, 821–824.
- Looareesuwan, S., Wilairatana, P., Vanijanonta, S., Kyle, D. & Webster, K. (1992d). Efficacy of quinine-tetracycline for acute uncomplicated falciparum malaria in Thailand. Lancet, i, 369.
- Navaratnam, V., Mahamad, M., Mansor, S. M. & Wernsdorfer, W. (1992). Pharmacokinetics of mefloquine: a comparison of two commercial formulations. In Proceedings of the 13th International Congress for Tropical Medicine and Malaria, Thailand, p. 281.
- Nosten, F., Imvithaya, S., Vincenti, M., Delmas, G., Libihar, G., Hausler, B. & White, N. J. (1987). Malaria on the Thai-Burmese border: treatment of 5192 patients with mefloquine-sulfadoxine-pyrimethamine. Bulletin of the World Health Organization, 65, 891–896.
- Nosten, F., Ter Kuile, F., Chongsuphajaisiddhi, T., Luxemburger, C., Webster, H. K., Edstein, M., Phaipun, L., Lay Thew, K. & White, N. J. (1991). Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet, i, 1140–1143.
- Ter Kuile, F., Dolan, G., Nosten, F., Edstein, M., Luxemburger, C., Phaipun, L., Chongsuphajaisiddhi, T., Webster, H. K. & White, N. J. (1993). Halo-fantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria. Lancet, i, 1044–1049.
- Ter Kuile, F., Nosten, F., Thieren, M., Luxemburger, C., Edstein, M. D., Chongsuphajaisiddhi, T., Phaipum, L., Webster, H. K. & White, N. J. (1992). High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria. Journal of Infectious Diseases, 166, 1303–1340.
- Warrell, D. A., Molyneux, M. E. & Beales, P. F. (1990). Severe and complicated malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84(Suppl. 2), 1–65.
- World Health Organization (1973). Advances in Malaria Chemotherapy. Technical Report Series No. 529. Geneva: WHO.